A detailed history of Harbor Capital Advisors, Inc. transactions in Biolife Solutions Inc stock. As of the latest transaction made, Harbor Capital Advisors, Inc. holds 40,028 shares of BLFS stock, worth $973,881. This represents 0.07% of its overall portfolio holdings.

Number of Shares
40,028
Previous 9,727 311.51%
Holding current value
$973,881
Previous $180,000 376.67%
% of portfolio
0.07%
Previous 0.02%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 09, 2024

BUY
$15.14 - $22.99 $458,757 - $696,619
30,301 Added 311.51%
40,028 $858,000
Q1 2024

May 13, 2024

BUY
$15.35 - $18.82 $149,309 - $183,062
9,727 New
9,727 $180,000
Q2 2023

Jul 11, 2023

BUY
$17.19 - $24.34 $16,811 - $23,804
978 New
978 $21,000

Others Institutions Holding BLFS

About BIOLIFE SOLUTIONS INC


  • Ticker BLFS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 42,684,400
  • Market Cap $1.04B
  • Description
  • BioLife Solutions, Inc. develops, manufactures, and supplies bioproduction tools and services for the cell and gene therapy industry in the United States, Canada, Europe, the Middle East, Africa, and internationally. The company's products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It of...
More about BLFS
Track This Portfolio

Track Harbor Capital Advisors, Inc. Portfolio

Follow Harbor Capital Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Harbor Capital Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Harbor Capital Advisors, Inc. with notifications on news.